7/11/18: The commercial launch follows the country-wide reimbursement approval under Japan's National Health Insurance granted this month and the Japanese Ministry of Health, Labour and Welfare regulatory approval received in July 2017.
CardioFocus® Announces Initiation Of Three Major Studies Featuring The HeartLight® System For The Treatment Of Atrial Fibrillation
CardioFocus, Inc., today announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical studies currently underway. Collectively, up to 1,000 AF patients will be enrolled in these studies. #cardiofocusinc #heartlight®systemforthetreatmentofatrialfibrillation
12Page 2 of 2